Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AVP-893: a prototype of a novel class of antitumor agents designed at Avanir

July 15, 2003

Novel methionine aminopeptidase type 2 inhibitors discovered by GSK scientists

July 15, 2003

Optimization of CDK-2 inhibitor series as orally active antitumor agents

July 14, 2003

BMS presents second-generation farnesyltransferase inhibitors at AACR meeting

July 14, 2003

Ivax initiates phase II trial of talampanel for brain cancer

July 14, 2003

Enrollment completed for phase I/II study of 131I-TM-601 in glioma

July 14, 2003

Promising activity reported for Nipent combination therapy in NHL

July 14, 2003

New antiproliferative agents in Sankyo development pipeline

July 14, 2003

Cytotoxic macrolactones discovered at GBF assumed to act by inhibiting V-ATPase

July 14, 2003

New telomerase inhibitors under study at Kyowa Hakko

July 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...